Review



cleaved c  (Quidel)


Bioz Verified Symbol Quidel is a verified supplier
Bioz Manufacturer Symbol Quidel manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Quidel cleaved c
    Cleaved C, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 74 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/FGF-23+ELISA/pmc12938118-84-35-38
    Average 95 stars, based on 74 article reviews
    cleaved c - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Markers of mineral metabolism in children with CKD stages 2-5D
    Article Snippet: Analyses of 1,25(OH)2D3 were performed using the Liaison system (DiaSorin S.p.A., Saluggia, Italy). .. Enzyme-linked immunosorbent assay (ELISA) kits were used for quantitative determination of intact FGF23 (iFGF23) (Quidel, Catalog # 60-6600, RRID: AB_2891250), total FGF23 using the C-term FGF23 assay kit, which measures both the full-length hormone and its posttranslationally cleaved C-terminal fragments (Quidel, Catalog # 60-6100, RRID: AB_2722648), sKlotho (Immuno Biological Laboratories, Catalog # 27998, RRID: AB_2750859) in plasma, and sclerostin (TECO Jo urn al Pr e-p roo f 6 Medical, Catalog # TE1023-HS, RRID: AB_2894880) in serum. .. All assays were performed essentially as described by the manufacturers and were measured in duplicate using Tecan Infinite M200Pro (Tecan Group, Männedorf, Switzerland) and quantified with Magellan 7.2 software.

    Clinical Proteomics:

    Article Title: Markers of mineral metabolism in children with CKD stages 2-5D
    Article Snippet: Analyses of 1,25(OH)2D3 were performed using the Liaison system (DiaSorin S.p.A., Saluggia, Italy). .. Enzyme-linked immunosorbent assay (ELISA) kits were used for quantitative determination of intact FGF23 (iFGF23) (Quidel, Catalog # 60-6600, RRID: AB_2891250), total FGF23 using the C-term FGF23 assay kit, which measures both the full-length hormone and its posttranslationally cleaved C-terminal fragments (Quidel, Catalog # 60-6100, RRID: AB_2722648), sKlotho (Immuno Biological Laboratories, Catalog # 27998, RRID: AB_2750859) in plasma, and sclerostin (TECO Jo urn al Pr e-p roo f 6 Medical, Catalog # TE1023-HS, RRID: AB_2894880) in serum. .. All assays were performed essentially as described by the manufacturers and were measured in duplicate using Tecan Infinite M200Pro (Tecan Group, Männedorf, Switzerland) and quantified with Magellan 7.2 software.

    Article Title: Markers of Mineral Metabolism in Children With CKD Stages 2 to 5D
    Article Snippet: Analyses of 1,25(OH) 2 D 3 were performed using the Liaison system (DiaSorin S.p.A., Saluggia, Italy). .. Enzyme-linked immunosorbent assay kits were used for quantitative determination of iFGF23 (Quidel, Catalog # 60-6600, RRID: AB_2891250 ), total FGF23 using the C-term FGF23 assay kit, which measures both the full-length hormone and its posttranslationally cleaved C-terminal fragments (Quidel, Catalog # 60-6100, RRID: AB_2722648 ), sKlotho (Immuno Biological Laboratories, Catalog # 27998, RRID: AB_2750859 ) in plasma, and sclerostin (TECO Medical, Catalog # TE1023-HS, RRID: AB_2894880 ) in serum. .. All assays were performed essentially as described by the manufacturers and were measured in duplicate using Tecan Infinite M200Pro (Tecan Group, Männedorf, Switzerland) and quantified with Magellan 7.2 software (Tecan Austria GmbH, Grödig, Austria).



    Similar Products

    94
    MedChemExpress c caspase 1
    Assessment of survival, lung pathology, STING palmitoylation, and inflammatory markers in sepsis-induced acute lung injury. The cecal ligation and puncture (CLP) model was utilized to create sepsis-related acute lung injury (ALI). Samples were harvested for analysis 72 h after CLP. The NLRP3/AIM2-IN-3 group received an intravenous injection through the tail vein immediately after CLP induction at a dose of 10 mg/kg. ( A ) Survival rates were compared using Kaplan-Meier survival curves among Sham-operated mice, CLP-induced sepsis mice, and CLP-induced sepsis mice treated with the NLRP3/AIM2 inhibitor NLRP3/AIM2-IN-3 (CLP + NLRP3/AIM2-IN-3). ( B ) Lung tissues from Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups were subjected to hematoxylin and eosin (HE) staining for assessment of pathological changes (scale bar = 100 μm). ( C ) Lung injury was quantitatively assessed based on histological criteria, providing injury scores for Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. ( D ) STING palmitoylation levels in lung tissues were measured using the Acyl-resin-assisted capture (Acyl-RAC) assay in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. ( E ) Lung tissue sections underwent immunohistochemistry (IHC) staining to assess the expression of ZDHHC21, <t>cleaved</t> <t>Caspase-1</t> (c-Caspase-1), and the cleaved form of Gasdermin D (GSDMD-N) in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups (scale bar = 100 μm). ( F ) Protein levels of ZDHHC21,TBK1, p-TBK1, IRF3, p-IRF3, c-Caspase-1, and GSDMD-N were quantified in lung tissues from Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups using Western blotting. ( G ) Levels of the inflammatory cytokines IL-18 and IL-1β in lung tissues were measured by enzyme-linked immunosorbent assay (ELISA) in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. Data are presented as mean ± SD. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test. n = 8 mice per group. * p < 0.05, ** p < 0.01, *** p < 0.001
    C Caspase 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/Cleaved-Caspase-1+Antibody/pmc12799895-108-15-20
    Average 94 stars, based on 1 article reviews
    c caspase 1 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    95
    Quidel cleaved c
    Assessment of survival, lung pathology, STING palmitoylation, and inflammatory markers in sepsis-induced acute lung injury. The cecal ligation and puncture (CLP) model was utilized to create sepsis-related acute lung injury (ALI). Samples were harvested for analysis 72 h after CLP. The NLRP3/AIM2-IN-3 group received an intravenous injection through the tail vein immediately after CLP induction at a dose of 10 mg/kg. ( A ) Survival rates were compared using Kaplan-Meier survival curves among Sham-operated mice, CLP-induced sepsis mice, and CLP-induced sepsis mice treated with the NLRP3/AIM2 inhibitor NLRP3/AIM2-IN-3 (CLP + NLRP3/AIM2-IN-3). ( B ) Lung tissues from Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups were subjected to hematoxylin and eosin (HE) staining for assessment of pathological changes (scale bar = 100 μm). ( C ) Lung injury was quantitatively assessed based on histological criteria, providing injury scores for Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. ( D ) STING palmitoylation levels in lung tissues were measured using the Acyl-resin-assisted capture (Acyl-RAC) assay in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. ( E ) Lung tissue sections underwent immunohistochemistry (IHC) staining to assess the expression of ZDHHC21, <t>cleaved</t> <t>Caspase-1</t> (c-Caspase-1), and the cleaved form of Gasdermin D (GSDMD-N) in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups (scale bar = 100 μm). ( F ) Protein levels of ZDHHC21,TBK1, p-TBK1, IRF3, p-IRF3, c-Caspase-1, and GSDMD-N were quantified in lung tissues from Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups using Western blotting. ( G ) Levels of the inflammatory cytokines IL-18 and IL-1β in lung tissues were measured by enzyme-linked immunosorbent assay (ELISA) in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. Data are presented as mean ± SD. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test. n = 8 mice per group. * p < 0.05, ** p < 0.01, *** p < 0.001
    Cleaved C, supplied by Quidel, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/FGF-23+ELISA/pmc12938118-84-35-38
    Average 95 stars, based on 1 article reviews
    cleaved c - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    94
    R&D Systems c cas3
    Combination trabectedin and anti-PD1 ICB prolongs survival of glioma-bearing mice (A) Schematic depicting the treatment regimen for the Ntv-a x XFM-luc RCAS murine glioma progression model. Four groups of mice were treated with vehicle, trabectedin (2 doses, 1 week apart, starting at week 4), anti-PD-1 immune checkpoint blockade (ICB; 3 doses, 3 days apart, starting at week 3.5), or a combination of trabectedin and anti-PD-1 ICB. (B) Kaplan-Meier survival analysis of the four treatment groups. Vehicle ( n = 12), anti-PD1 ( n = 8), trabectedin ( n = 13), and trabectedin + anti-PD1 ( n = 12) had median survivals of 39, 43, 43, and 53 days, respectively. Significance was determined using the log-rank (Mantel-Cox) test ( p < 0.0001∗∗∗∗, p < 0.0002 ∗∗∗, p < 0.0021∗∗, p < 0.0332∗). (C) Representative images of cleaved caspase-3 <t>(c-cas3)</t> immunohistochemical (IHC) staining of tumors isolated from glioma-bearing mice 3 days post treatment 2 (3DPT2) with vehicle, trabectedin, or trabectedin + anti-PD1 combination. (D) Quantification of c-cas3 IHC staining. Positive pixels were calculated by sampling 5 equal-sized regions within each tumor core and comparing the number of positive pixels per region ( n = 2–5 mice per treatment group). Significance was determined using a paired t test with Welch’s correction ( p < 0.0005∗∗∗∗, p < 0.005 ∗∗∗, p < 0.005∗∗, p < 0.05∗). Error bars show SD.
    C Cas3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/Human%2FMouse+Cleaved+Caspase-3+(Asp175)+Antibody/pmc12936832-253-8-9
    Average 94 stars, based on 1 article reviews
    c cas3 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc rabbit anti c cas3 antibody
    Combination trabectedin and anti-PD1 ICB prolongs survival of glioma-bearing mice (A) Schematic depicting the treatment regimen for the Ntv-a x XFM-luc RCAS murine glioma progression model. Four groups of mice were treated with vehicle, trabectedin (2 doses, 1 week apart, starting at week 4), anti-PD-1 immune checkpoint blockade (ICB; 3 doses, 3 days apart, starting at week 3.5), or a combination of trabectedin and anti-PD-1 ICB. (B) Kaplan-Meier survival analysis of the four treatment groups. Vehicle ( n = 12), anti-PD1 ( n = 8), trabectedin ( n = 13), and trabectedin + anti-PD1 ( n = 12) had median survivals of 39, 43, 43, and 53 days, respectively. Significance was determined using the log-rank (Mantel-Cox) test ( p < 0.0001∗∗∗∗, p < 0.0002 ∗∗∗, p < 0.0021∗∗, p < 0.0332∗). (C) Representative images of cleaved caspase-3 <t>(c-cas3)</t> immunohistochemical (IHC) staining of tumors isolated from glioma-bearing mice 3 days post treatment 2 (3DPT2) with vehicle, trabectedin, or trabectedin + anti-PD1 combination. (D) Quantification of c-cas3 IHC staining. Positive pixels were calculated by sampling 5 equal-sized regions within each tumor core and comparing the number of positive pixels per region ( n = 2–5 mice per treatment group). Significance was determined using a paired t test with Welch’s correction ( p < 0.0005∗∗∗∗, p < 0.005 ∗∗∗, p < 0.005∗∗, p < 0.05∗). Error bars show SD.
    Rabbit Anti C Cas3 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/Cleaved+Caspase-3+(Asp175)+Rabbit+mAb/pmc12757552-138-13-17
    Average 99 stars, based on 1 article reviews
    rabbit anti c cas3 antibody - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc anti c capase3
    Combination trabectedin and anti-PD1 ICB prolongs survival of glioma-bearing mice (A) Schematic depicting the treatment regimen for the Ntv-a x XFM-luc RCAS murine glioma progression model. Four groups of mice were treated with vehicle, trabectedin (2 doses, 1 week apart, starting at week 4), anti-PD-1 immune checkpoint blockade (ICB; 3 doses, 3 days apart, starting at week 3.5), or a combination of trabectedin and anti-PD-1 ICB. (B) Kaplan-Meier survival analysis of the four treatment groups. Vehicle ( n = 12), anti-PD1 ( n = 8), trabectedin ( n = 13), and trabectedin + anti-PD1 ( n = 12) had median survivals of 39, 43, 43, and 53 days, respectively. Significance was determined using the log-rank (Mantel-Cox) test ( p < 0.0001∗∗∗∗, p < 0.0002 ∗∗∗, p < 0.0021∗∗, p < 0.0332∗). (C) Representative images of cleaved caspase-3 <t>(c-cas3)</t> immunohistochemical (IHC) staining of tumors isolated from glioma-bearing mice 3 days post treatment 2 (3DPT2) with vehicle, trabectedin, or trabectedin + anti-PD1 combination. (D) Quantification of c-cas3 IHC staining. Positive pixels were calculated by sampling 5 equal-sized regions within each tumor core and comparing the number of positive pixels per region ( n = 2–5 mice per treatment group). Significance was determined using a paired t test with Welch’s correction ( p < 0.0005∗∗∗∗, p < 0.005 ∗∗∗, p < 0.005∗∗, p < 0.05∗). Error bars show SD.
    Anti C Capase3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/Cleaved+Caspase-3+(Asp175)+Antibody/pm41606648-282-27-34
    Average 99 stars, based on 1 article reviews
    anti c capase3 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc c caspase 3
    Combination trabectedin and anti-PD1 ICB prolongs survival of glioma-bearing mice (A) Schematic depicting the treatment regimen for the Ntv-a x XFM-luc RCAS murine glioma progression model. Four groups of mice were treated with vehicle, trabectedin (2 doses, 1 week apart, starting at week 4), anti-PD-1 immune checkpoint blockade (ICB; 3 doses, 3 days apart, starting at week 3.5), or a combination of trabectedin and anti-PD-1 ICB. (B) Kaplan-Meier survival analysis of the four treatment groups. Vehicle ( n = 12), anti-PD1 ( n = 8), trabectedin ( n = 13), and trabectedin + anti-PD1 ( n = 12) had median survivals of 39, 43, 43, and 53 days, respectively. Significance was determined using the log-rank (Mantel-Cox) test ( p < 0.0001∗∗∗∗, p < 0.0002 ∗∗∗, p < 0.0021∗∗, p < 0.0332∗). (C) Representative images of cleaved caspase-3 <t>(c-cas3)</t> immunohistochemical (IHC) staining of tumors isolated from glioma-bearing mice 3 days post treatment 2 (3DPT2) with vehicle, trabectedin, or trabectedin + anti-PD1 combination. (D) Quantification of c-cas3 IHC staining. Positive pixels were calculated by sampling 5 equal-sized regions within each tumor core and comparing the number of positive pixels per region ( n = 2–5 mice per treatment group). Significance was determined using a paired t test with Welch’s correction ( p < 0.0005∗∗∗∗, p < 0.005 ∗∗∗, p < 0.005∗∗, p < 0.05∗). Error bars show SD.
    C Caspase 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/Cleaved+Caspase-3+(Asp175)+Antibody/pmc12830502-33-0-3
    Average 99 stars, based on 1 article reviews
    c caspase 3 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc anti cleaved caspase 3 c cas 3
    CCL24 blockade reduces CRC incidence and progression in vivo . A, Correlation analysis of CCL24 expression with T cell dysfunction and TAM-related marker genes in the TCGA-COAD dataset. B, TMA analysis of CCL24 staining intensity in tumor and adjacent tissues from 84 CRC patients. C-D, qPCR and ELISA detection of CCL24 mRNA and secretion levels in colon epithelial cells (FHC) and CRC cell lines (HCT116, Lovo, SW480, MC38). E, a primary CRC model was established in C57BL/6 mice through AOM/DSS induction, followed by tail vein injection of anti-CCL24 (ACl24, 10 μg/kg/week) after 8 weeks for CCL24 blockade. F, Gross images of mouse colons with primary tumors. G, Tumor number and diameter in mouse colons. H, IHC <t>detection</t> <t>of</t> <t>C-Cas-3</t> positive staining in tumor tissues. I, Flow cytometry analysis of Arg1 + Mrc1 + TAMs in mouse colon tissues. TMA includes 84 pairs of tissue samples. Cell experiments repeated 6-8 times. Animal experiments include 6-8 mice per group. Data are presented as bars and dots. p < 0.05 was considered statistically significant.
    Anti Cleaved Caspase 3 C Cas 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/Caspase-3+Antibody/pmc12905639-123-4-9
    Average 99 stars, based on 1 article reviews
    anti cleaved caspase 3 c cas 3 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    99
    Cell Signaling Technology Inc c caspase3
    Overexpression of Rhbdf2 exacerbated H/R-induced apoptosis and inflammatory response, whereas downregulation of Rhbdf2 significantly alleviates H/R-induced liver injury. ( A ) Analysis of Rhbdf2 protein and mRNA expression levels in Rhbdf2 overexpressing cell lines (OE) and vector control cell lines (VT) by Western blot and qRT-PCR analyses (n = 3 per group). ( B ) Western blot analysis of the protein expression levels and quantification of Bax, Bcl2, and C-caspase 3 in the OE group and the VT group before and after H/R (n = 3 per group). ( C ) Flow cytometry analysis of apoptosis rate and statistical analysis of cells in the OE and VT groups after H/R (n = 3 per group). ( D ) qRT-PCR analysis of mRNA levels of IL-6, IL-1β, and TNF-α in the OE and VT groups after H/R (n = 3 per group). ( E ) Western blot analysis and quantification of the expression levels of NF-κB signaling pathway-related proteins in cells from the OE and VT groups before and after H/R (n = 3 per group). ( F ) Western blot analysis and qRT-PCR analysis to determine the protein and mRNA expression levels of Rhbdf2 respectively in Rhbdf2 knockdown cells (SH1, 2, 3) and control cells (NC) (n = 3 per group). ( G ) Western blot analysis of the protein expression levels of Bax, Bcl2, and <t>C-caspase3</t> in the cells of the SH1 and NC groups before and after H/R, and the results of statistical analysis (n = 3 per group). ( H ) Flow cytometry analysis of apoptosis rate of SH1 cells and NC cells before and after H/R, and statistical analysis (n = 3 per group). ( I ) qRT-PCR analysis of mRNA expression levels of inflammatory cytokines IL-6 , IL-1β, and TNF-α in SH1 and NC cells before and after H/R (n = 3 per group). ( J ) The expression levels and statistical analysis of NF-κB signaling pathway-related proteins in SH1 and NC cells before and after H/R (n = 3 per group). Using β-Actin as loading control; data are shown as the mean ± SD; ns indicates no statistical difference compared with control; ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001 indicate a statistical difference compared with control.
    C Caspase3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cleaved+c/Cleaved+Caspase-3+(Asp175)+Antibody/pmc12873737-35-0-2
    Average 99 stars, based on 1 article reviews
    c caspase3 - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    Image Search Results


    Assessment of survival, lung pathology, STING palmitoylation, and inflammatory markers in sepsis-induced acute lung injury. The cecal ligation and puncture (CLP) model was utilized to create sepsis-related acute lung injury (ALI). Samples were harvested for analysis 72 h after CLP. The NLRP3/AIM2-IN-3 group received an intravenous injection through the tail vein immediately after CLP induction at a dose of 10 mg/kg. ( A ) Survival rates were compared using Kaplan-Meier survival curves among Sham-operated mice, CLP-induced sepsis mice, and CLP-induced sepsis mice treated with the NLRP3/AIM2 inhibitor NLRP3/AIM2-IN-3 (CLP + NLRP3/AIM2-IN-3). ( B ) Lung tissues from Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups were subjected to hematoxylin and eosin (HE) staining for assessment of pathological changes (scale bar = 100 μm). ( C ) Lung injury was quantitatively assessed based on histological criteria, providing injury scores for Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. ( D ) STING palmitoylation levels in lung tissues were measured using the Acyl-resin-assisted capture (Acyl-RAC) assay in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. ( E ) Lung tissue sections underwent immunohistochemistry (IHC) staining to assess the expression of ZDHHC21, cleaved Caspase-1 (c-Caspase-1), and the cleaved form of Gasdermin D (GSDMD-N) in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups (scale bar = 100 μm). ( F ) Protein levels of ZDHHC21,TBK1, p-TBK1, IRF3, p-IRF3, c-Caspase-1, and GSDMD-N were quantified in lung tissues from Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups using Western blotting. ( G ) Levels of the inflammatory cytokines IL-18 and IL-1β in lung tissues were measured by enzyme-linked immunosorbent assay (ELISA) in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. Data are presented as mean ± SD. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test. n = 8 mice per group. * p < 0.05, ** p < 0.01, *** p < 0.001

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: Sepsis-induced acute lung injury: AUF1 regulates pyroptosis via ETS2/ZDHHC21-mediated STING palmitoylation

    doi: 10.1007/s00018-025-06038-4

    Figure Lengend Snippet: Assessment of survival, lung pathology, STING palmitoylation, and inflammatory markers in sepsis-induced acute lung injury. The cecal ligation and puncture (CLP) model was utilized to create sepsis-related acute lung injury (ALI). Samples were harvested for analysis 72 h after CLP. The NLRP3/AIM2-IN-3 group received an intravenous injection through the tail vein immediately after CLP induction at a dose of 10 mg/kg. ( A ) Survival rates were compared using Kaplan-Meier survival curves among Sham-operated mice, CLP-induced sepsis mice, and CLP-induced sepsis mice treated with the NLRP3/AIM2 inhibitor NLRP3/AIM2-IN-3 (CLP + NLRP3/AIM2-IN-3). ( B ) Lung tissues from Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups were subjected to hematoxylin and eosin (HE) staining for assessment of pathological changes (scale bar = 100 μm). ( C ) Lung injury was quantitatively assessed based on histological criteria, providing injury scores for Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. ( D ) STING palmitoylation levels in lung tissues were measured using the Acyl-resin-assisted capture (Acyl-RAC) assay in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. ( E ) Lung tissue sections underwent immunohistochemistry (IHC) staining to assess the expression of ZDHHC21, cleaved Caspase-1 (c-Caspase-1), and the cleaved form of Gasdermin D (GSDMD-N) in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups (scale bar = 100 μm). ( F ) Protein levels of ZDHHC21,TBK1, p-TBK1, IRF3, p-IRF3, c-Caspase-1, and GSDMD-N were quantified in lung tissues from Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups using Western blotting. ( G ) Levels of the inflammatory cytokines IL-18 and IL-1β in lung tissues were measured by enzyme-linked immunosorbent assay (ELISA) in Sham, CLP, and CLP + NLRP3/AIM2-IN-3 groups. Data are presented as mean ± SD. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test. n = 8 mice per group. * p < 0.05, ** p < 0.01, *** p < 0.001

    Article Snippet: Sections were incubated overnight at 4 °C with primary antibodies against ZDHHC21 (1:200, Invitrogen, PA5-25096), c-Caspase-1 (1:200, HY- P80622 ; MedChemExpress), and GSDMD-N (1:200, Invitrogen, PA5-116815).

    Techniques: Ligation, Injection, Staining, Immunohistochemistry, Expressing, Western Blot, Enzyme-linked Immunosorbent Assay

    Evaluation of cell viability, pyroptosis, STING palmitoylation, and inflammatory markers in an in vitro sepsis-induced acute lung injury model. MLE-12 cells were stimulated with LPS (1 µg/mL) to induce a sepsis-induced ALI cell model, with the control group receiving an equivalent volume of PBS. All assays were performed 24 h after LPS stimulation. The NLRP3/AIM2-IN-3 group was treated with 10 µM of NLRP3/AIM2-IN-3 1 h prior to LPS stimulation. ( A ) The CCK-8 assay was conducted to assess the cell viability in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. ( B ) Proportions of PI-positive and Caspase-1-positive cells were analyzed by flow cytometry in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. ( C ) STING palmitoylation levels were assessed using the Acyl-resin-assisted capture (Acyl-RAC) assay in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. ( D ) ZDHHC21, TBK1, p-TBK1, IRF3, p-IRF3, cleaved Caspase-1 (c-Caspase-1), and GSDMD-N protein expression were determined by Western blot analysis in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. ( E ) IL-1β and IL-18 concentrations in the cell culture supernatant were measured by ELISA in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. Data are presented as mean ± SD. Statistical significance was assessed using one-way ANOVA followed by Tukey’s post hoc test. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: Sepsis-induced acute lung injury: AUF1 regulates pyroptosis via ETS2/ZDHHC21-mediated STING palmitoylation

    doi: 10.1007/s00018-025-06038-4

    Figure Lengend Snippet: Evaluation of cell viability, pyroptosis, STING palmitoylation, and inflammatory markers in an in vitro sepsis-induced acute lung injury model. MLE-12 cells were stimulated with LPS (1 µg/mL) to induce a sepsis-induced ALI cell model, with the control group receiving an equivalent volume of PBS. All assays were performed 24 h after LPS stimulation. The NLRP3/AIM2-IN-3 group was treated with 10 µM of NLRP3/AIM2-IN-3 1 h prior to LPS stimulation. ( A ) The CCK-8 assay was conducted to assess the cell viability in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. ( B ) Proportions of PI-positive and Caspase-1-positive cells were analyzed by flow cytometry in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. ( C ) STING palmitoylation levels were assessed using the Acyl-resin-assisted capture (Acyl-RAC) assay in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. ( D ) ZDHHC21, TBK1, p-TBK1, IRF3, p-IRF3, cleaved Caspase-1 (c-Caspase-1), and GSDMD-N protein expression were determined by Western blot analysis in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. ( E ) IL-1β and IL-18 concentrations in the cell culture supernatant were measured by ELISA in control, LPS, and LPS + NLRP3/AIM2-IN-3 treated MLE-12 cells. Data are presented as mean ± SD. Statistical significance was assessed using one-way ANOVA followed by Tukey’s post hoc test. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001

    Article Snippet: Sections were incubated overnight at 4 °C with primary antibodies against ZDHHC21 (1:200, Invitrogen, PA5-25096), c-Caspase-1 (1:200, HY- P80622 ; MedChemExpress), and GSDMD-N (1:200, Invitrogen, PA5-116815).

    Techniques: In Vitro, Control, CCK-8 Assay, Flow Cytometry, Expressing, Western Blot, Cell Culture, Enzyme-linked Immunosorbent Assay

    ZDHHC21 knockdown inhibits STING palmitoylation and pyroptosis in LPS-treated MLE-12 cells. ( A ) Western blot to verify successful knockdown of ZDHHC21 in control and shRNA-treated MLE-12 cells. ( B ) Western blot analysis of ZDHHC21 expression in control, LPS, LPS + shNC, and LPS + shZDHHC21 groups. ( C ) Cell viability was assessed using the CCK-8 assay across different treatment groups. ( D ) Flow cytometry analysis of Caspase-1/PI positive rates in each group. ( E ) Acyl-RAC assay to evaluate STING palmitoylation levels in control, LPS, LPS + shNC, and LPS + shZDHHC21 treated cells. ( F ) Western blot detection of cleaved Caspase-1 (c-Caspase-1), TBK1, p-TBK1, IRF3, p-IRF3, and GSDMD-N expression levels. ( G ) ELISA measurements of IL-18 and IL-1β levels in cell culture supernatant. Data are presented as mean ± SD. One-way ANOVA was employed to determine statistical significance, with Tukey’s post hoc test applied afterward. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: Sepsis-induced acute lung injury: AUF1 regulates pyroptosis via ETS2/ZDHHC21-mediated STING palmitoylation

    doi: 10.1007/s00018-025-06038-4

    Figure Lengend Snippet: ZDHHC21 knockdown inhibits STING palmitoylation and pyroptosis in LPS-treated MLE-12 cells. ( A ) Western blot to verify successful knockdown of ZDHHC21 in control and shRNA-treated MLE-12 cells. ( B ) Western blot analysis of ZDHHC21 expression in control, LPS, LPS + shNC, and LPS + shZDHHC21 groups. ( C ) Cell viability was assessed using the CCK-8 assay across different treatment groups. ( D ) Flow cytometry analysis of Caspase-1/PI positive rates in each group. ( E ) Acyl-RAC assay to evaluate STING palmitoylation levels in control, LPS, LPS + shNC, and LPS + shZDHHC21 treated cells. ( F ) Western blot detection of cleaved Caspase-1 (c-Caspase-1), TBK1, p-TBK1, IRF3, p-IRF3, and GSDMD-N expression levels. ( G ) ELISA measurements of IL-18 and IL-1β levels in cell culture supernatant. Data are presented as mean ± SD. One-way ANOVA was employed to determine statistical significance, with Tukey’s post hoc test applied afterward. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001

    Article Snippet: Sections were incubated overnight at 4 °C with primary antibodies against ZDHHC21 (1:200, Invitrogen, PA5-25096), c-Caspase-1 (1:200, HY- P80622 ; MedChemExpress), and GSDMD-N (1:200, Invitrogen, PA5-116815).

    Techniques: Knockdown, Western Blot, Control, shRNA, Expressing, CCK-8 Assay, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Cell Culture

    AUF1 overexpression inhibits ETS2/ZDHHC21-mediated STING palmitoylation and pyroptosis in sepsis-induced ALI models. ( A ) Western blotting was utilized to measure AUF1 levels in lung tissues from Sham and CLP-induced sepsis mice. ( B ) Analysis of AUF1 protein levels in control and LPS-treated MLE-12 cells was carried out using Western blot. ( C ) Western blot analysis showing the expression levels of AUF1, ETS2, and ZDHHC21 in MLE-12 cells following AUF1 overexpression. NC: negative control; AUF1: AUF1 overexpression group. ( D ) Western blot analysis of AUF1, ETS2, and ZDHHC21 expression in MLE-12 cells under different conditions, including control, LPS, LPS + NC, and LPS + AUF1 overexpression. ( E ) Cell viability was assessed using the CCK-8 assay across different treatment groups. ( F ) Flow cytometry analysis of Caspase-1/PI-positive rates to evaluate pyroptosis levels. ( G ) Acyl-RAC assay to evaluate STING palmitoylation levels in different groups. ( H ) Western blot analysis of TBK1, p-TBK1, IRF3, p-IRF3, cleaved Caspase-1 (c-Caspase-1), and GSDMD-N expression levels. ( I ) ELISA measurements of IL-1β and IL-18 concentrations in cell culture supernatant. Data are presented as mean ± SD. Statistical significance was evaluated through one-way ANOVA with subsequent analysis using Tukey’s post hoc test, as well as two-tailed Student’s t-test for comparisons between two groups. n = 8 for A, n = 3 for B-I. * p < 0.05, ** p < 0.01, *** p < 0.001

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: Sepsis-induced acute lung injury: AUF1 regulates pyroptosis via ETS2/ZDHHC21-mediated STING palmitoylation

    doi: 10.1007/s00018-025-06038-4

    Figure Lengend Snippet: AUF1 overexpression inhibits ETS2/ZDHHC21-mediated STING palmitoylation and pyroptosis in sepsis-induced ALI models. ( A ) Western blotting was utilized to measure AUF1 levels in lung tissues from Sham and CLP-induced sepsis mice. ( B ) Analysis of AUF1 protein levels in control and LPS-treated MLE-12 cells was carried out using Western blot. ( C ) Western blot analysis showing the expression levels of AUF1, ETS2, and ZDHHC21 in MLE-12 cells following AUF1 overexpression. NC: negative control; AUF1: AUF1 overexpression group. ( D ) Western blot analysis of AUF1, ETS2, and ZDHHC21 expression in MLE-12 cells under different conditions, including control, LPS, LPS + NC, and LPS + AUF1 overexpression. ( E ) Cell viability was assessed using the CCK-8 assay across different treatment groups. ( F ) Flow cytometry analysis of Caspase-1/PI-positive rates to evaluate pyroptosis levels. ( G ) Acyl-RAC assay to evaluate STING palmitoylation levels in different groups. ( H ) Western blot analysis of TBK1, p-TBK1, IRF3, p-IRF3, cleaved Caspase-1 (c-Caspase-1), and GSDMD-N expression levels. ( I ) ELISA measurements of IL-1β and IL-18 concentrations in cell culture supernatant. Data are presented as mean ± SD. Statistical significance was evaluated through one-way ANOVA with subsequent analysis using Tukey’s post hoc test, as well as two-tailed Student’s t-test for comparisons between two groups. n = 8 for A, n = 3 for B-I. * p < 0.05, ** p < 0.01, *** p < 0.001

    Article Snippet: Sections were incubated overnight at 4 °C with primary antibodies against ZDHHC21 (1:200, Invitrogen, PA5-25096), c-Caspase-1 (1:200, HY- P80622 ; MedChemExpress), and GSDMD-N (1:200, Invitrogen, PA5-116815).

    Techniques: Over Expression, Western Blot, Control, Expressing, Negative Control, CCK-8 Assay, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Cell Culture, Two Tailed Test

    AUF1 inhibits STING palmitoylation-mediated pyroptosis through the ETS2/ZDHHC21 axis in sepsis-induced ALI. ( A ) Western blot analysis of AUF1, ETS2, and ZDHHC21 protein expression in MLE-12 cells overexpressing AUF1, ETS2, or both. NC: negative control; AUF1: AUF1 overexpression group; ETS2: ETS2 overexpression group; AUF1 + ETS2: AUF1 and ETS2 both overexpression group. ( B ) Western blot analysis of AUF1, ETS2, and ZDHHC21 protein levels in MLE-12 cells treated with LPS following overexpression of AUF1, ETS2, or both. ( C ) CCK-8 assay measuring cell viability across different treatment groups following LPS stimulation. ( D ) Flow cytometry analysis of Caspase-1 and PI-positive rates to evaluate pyroptosis levels in each treatment group following LPS stimulation. ( E ) Acyl-RAC assay assessing STING palmitoylation levels in various treatment groups following LPS stimulation. ( F ) Western blot analysis of TBK1, p-TBK1, IRF3, p-IRF3, cleaved Caspase-1 (c-Caspase-1), and GSDMD-N in each treatment group following LPS stimulation. ( G ) ELISA measurements of pro-inflammatory cytokines IL-1β and IL-18 in cell culture supernatants across different treatment groups following LPS stimulation. Data are presented as mean ± SD. One-way ANOVA was performed to establish statistical significance, followed by Tukey’s post hoc test for detailed comparison. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: Sepsis-induced acute lung injury: AUF1 regulates pyroptosis via ETS2/ZDHHC21-mediated STING palmitoylation

    doi: 10.1007/s00018-025-06038-4

    Figure Lengend Snippet: AUF1 inhibits STING palmitoylation-mediated pyroptosis through the ETS2/ZDHHC21 axis in sepsis-induced ALI. ( A ) Western blot analysis of AUF1, ETS2, and ZDHHC21 protein expression in MLE-12 cells overexpressing AUF1, ETS2, or both. NC: negative control; AUF1: AUF1 overexpression group; ETS2: ETS2 overexpression group; AUF1 + ETS2: AUF1 and ETS2 both overexpression group. ( B ) Western blot analysis of AUF1, ETS2, and ZDHHC21 protein levels in MLE-12 cells treated with LPS following overexpression of AUF1, ETS2, or both. ( C ) CCK-8 assay measuring cell viability across different treatment groups following LPS stimulation. ( D ) Flow cytometry analysis of Caspase-1 and PI-positive rates to evaluate pyroptosis levels in each treatment group following LPS stimulation. ( E ) Acyl-RAC assay assessing STING palmitoylation levels in various treatment groups following LPS stimulation. ( F ) Western blot analysis of TBK1, p-TBK1, IRF3, p-IRF3, cleaved Caspase-1 (c-Caspase-1), and GSDMD-N in each treatment group following LPS stimulation. ( G ) ELISA measurements of pro-inflammatory cytokines IL-1β and IL-18 in cell culture supernatants across different treatment groups following LPS stimulation. Data are presented as mean ± SD. One-way ANOVA was performed to establish statistical significance, followed by Tukey’s post hoc test for detailed comparison. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001

    Article Snippet: Sections were incubated overnight at 4 °C with primary antibodies against ZDHHC21 (1:200, Invitrogen, PA5-25096), c-Caspase-1 (1:200, HY- P80622 ; MedChemExpress), and GSDMD-N (1:200, Invitrogen, PA5-116815).

    Techniques: Western Blot, Expressing, Negative Control, Over Expression, CCK-8 Assay, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Cell Culture, Comparison

    Molecular mechanism of AUF1-regulated pyroptosis via ETS2/ZDHHC21/STING pathway in ALI. In sepsis-induced ALI, AUF1 expression is downregulated in lung epithelial cells, resulting in reduced decay of ETS2 mRNA and subsequent upregulation of ETS2. Elevated ETS2 directly activates the transcription of ZDHHC21, a palmitoyltransferase, leading to increased STING palmitoylation. Activated STING signaling promotes the phosphorylation of TBK1 and IRF3, ultimately enhancing pyroptosis via upregulation of c-Caspase-1, GSDMD-N, IL-18, and IL-1β. Overexpression of AUF1 promotes the decay of ETS2 mRNA, thereby suppressing the ETS2/ZDHHC21/STING axis, reducing STING palmitoylation and downstream pyroptosis, and alleviating lung injury. This pathway highlights AUF1 as a potential therapeutic target for sepsis-induced ALI

    Journal: Cellular and Molecular Life Sciences: CMLS

    Article Title: Sepsis-induced acute lung injury: AUF1 regulates pyroptosis via ETS2/ZDHHC21-mediated STING palmitoylation

    doi: 10.1007/s00018-025-06038-4

    Figure Lengend Snippet: Molecular mechanism of AUF1-regulated pyroptosis via ETS2/ZDHHC21/STING pathway in ALI. In sepsis-induced ALI, AUF1 expression is downregulated in lung epithelial cells, resulting in reduced decay of ETS2 mRNA and subsequent upregulation of ETS2. Elevated ETS2 directly activates the transcription of ZDHHC21, a palmitoyltransferase, leading to increased STING palmitoylation. Activated STING signaling promotes the phosphorylation of TBK1 and IRF3, ultimately enhancing pyroptosis via upregulation of c-Caspase-1, GSDMD-N, IL-18, and IL-1β. Overexpression of AUF1 promotes the decay of ETS2 mRNA, thereby suppressing the ETS2/ZDHHC21/STING axis, reducing STING palmitoylation and downstream pyroptosis, and alleviating lung injury. This pathway highlights AUF1 as a potential therapeutic target for sepsis-induced ALI

    Article Snippet: Sections were incubated overnight at 4 °C with primary antibodies against ZDHHC21 (1:200, Invitrogen, PA5-25096), c-Caspase-1 (1:200, HY- P80622 ; MedChemExpress), and GSDMD-N (1:200, Invitrogen, PA5-116815).

    Techniques: Expressing, Phospho-proteomics, Over Expression

    Combination trabectedin and anti-PD1 ICB prolongs survival of glioma-bearing mice (A) Schematic depicting the treatment regimen for the Ntv-a x XFM-luc RCAS murine glioma progression model. Four groups of mice were treated with vehicle, trabectedin (2 doses, 1 week apart, starting at week 4), anti-PD-1 immune checkpoint blockade (ICB; 3 doses, 3 days apart, starting at week 3.5), or a combination of trabectedin and anti-PD-1 ICB. (B) Kaplan-Meier survival analysis of the four treatment groups. Vehicle ( n = 12), anti-PD1 ( n = 8), trabectedin ( n = 13), and trabectedin + anti-PD1 ( n = 12) had median survivals of 39, 43, 43, and 53 days, respectively. Significance was determined using the log-rank (Mantel-Cox) test ( p < 0.0001∗∗∗∗, p < 0.0002 ∗∗∗, p < 0.0021∗∗, p < 0.0332∗). (C) Representative images of cleaved caspase-3 (c-cas3) immunohistochemical (IHC) staining of tumors isolated from glioma-bearing mice 3 days post treatment 2 (3DPT2) with vehicle, trabectedin, or trabectedin + anti-PD1 combination. (D) Quantification of c-cas3 IHC staining. Positive pixels were calculated by sampling 5 equal-sized regions within each tumor core and comparing the number of positive pixels per region ( n = 2–5 mice per treatment group). Significance was determined using a paired t test with Welch’s correction ( p < 0.0005∗∗∗∗, p < 0.005 ∗∗∗, p < 0.005∗∗, p < 0.05∗). Error bars show SD.

    Journal: Molecular Therapy Oncology

    Article Title: Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression

    doi: 10.1016/j.omton.2026.201147

    Figure Lengend Snippet: Combination trabectedin and anti-PD1 ICB prolongs survival of glioma-bearing mice (A) Schematic depicting the treatment regimen for the Ntv-a x XFM-luc RCAS murine glioma progression model. Four groups of mice were treated with vehicle, trabectedin (2 doses, 1 week apart, starting at week 4), anti-PD-1 immune checkpoint blockade (ICB; 3 doses, 3 days apart, starting at week 3.5), or a combination of trabectedin and anti-PD-1 ICB. (B) Kaplan-Meier survival analysis of the four treatment groups. Vehicle ( n = 12), anti-PD1 ( n = 8), trabectedin ( n = 13), and trabectedin + anti-PD1 ( n = 12) had median survivals of 39, 43, 43, and 53 days, respectively. Significance was determined using the log-rank (Mantel-Cox) test ( p < 0.0001∗∗∗∗, p < 0.0002 ∗∗∗, p < 0.0021∗∗, p < 0.0332∗). (C) Representative images of cleaved caspase-3 (c-cas3) immunohistochemical (IHC) staining of tumors isolated from glioma-bearing mice 3 days post treatment 2 (3DPT2) with vehicle, trabectedin, or trabectedin + anti-PD1 combination. (D) Quantification of c-cas3 IHC staining. Positive pixels were calculated by sampling 5 equal-sized regions within each tumor core and comparing the number of positive pixels per region ( n = 2–5 mice per treatment group). Significance was determined using a paired t test with Welch’s correction ( p < 0.0005∗∗∗∗, p < 0.005 ∗∗∗, p < 0.005∗∗, p < 0.05∗). Error bars show SD.

    Article Snippet: Slides were washed in TBST and stained with c-cas3 (R&D Systems MAB835, Minneapolis, MN) at a 1:100 dilution for 2 h at room temperature.

    Techniques: Immunohistochemical staining, Immunohistochemistry, Isolation, Sampling

    CCL24 blockade reduces CRC incidence and progression in vivo . A, Correlation analysis of CCL24 expression with T cell dysfunction and TAM-related marker genes in the TCGA-COAD dataset. B, TMA analysis of CCL24 staining intensity in tumor and adjacent tissues from 84 CRC patients. C-D, qPCR and ELISA detection of CCL24 mRNA and secretion levels in colon epithelial cells (FHC) and CRC cell lines (HCT116, Lovo, SW480, MC38). E, a primary CRC model was established in C57BL/6 mice through AOM/DSS induction, followed by tail vein injection of anti-CCL24 (ACl24, 10 μg/kg/week) after 8 weeks for CCL24 blockade. F, Gross images of mouse colons with primary tumors. G, Tumor number and diameter in mouse colons. H, IHC detection of C-Cas-3 positive staining in tumor tissues. I, Flow cytometry analysis of Arg1 + Mrc1 + TAMs in mouse colon tissues. TMA includes 84 pairs of tissue samples. Cell experiments repeated 6-8 times. Animal experiments include 6-8 mice per group. Data are presented as bars and dots. p < 0.05 was considered statistically significant.

    Journal: International Journal of Biological Sciences

    Article Title: CCL24 recruits CCR3 + TAMs to promote immunosuppression via YAP1 activation and serves as a therapeutic target for Gracillin in colorectal cancer

    doi: 10.7150/ijbs.127341

    Figure Lengend Snippet: CCL24 blockade reduces CRC incidence and progression in vivo . A, Correlation analysis of CCL24 expression with T cell dysfunction and TAM-related marker genes in the TCGA-COAD dataset. B, TMA analysis of CCL24 staining intensity in tumor and adjacent tissues from 84 CRC patients. C-D, qPCR and ELISA detection of CCL24 mRNA and secretion levels in colon epithelial cells (FHC) and CRC cell lines (HCT116, Lovo, SW480, MC38). E, a primary CRC model was established in C57BL/6 mice through AOM/DSS induction, followed by tail vein injection of anti-CCL24 (ACl24, 10 μg/kg/week) after 8 weeks for CCL24 blockade. F, Gross images of mouse colons with primary tumors. G, Tumor number and diameter in mouse colons. H, IHC detection of C-Cas-3 positive staining in tumor tissues. I, Flow cytometry analysis of Arg1 + Mrc1 + TAMs in mouse colon tissues. TMA includes 84 pairs of tissue samples. Cell experiments repeated 6-8 times. Animal experiments include 6-8 mice per group. Data are presented as bars and dots. p < 0.05 was considered statistically significant.

    Article Snippet: IHC was performed using anti-Cleaved-Caspase-3 (C-Cas-3) and anti-CCR3 antibodies (Cell Signaling Technology), with secondary antibodies visualized using a DAB detection system (ZSGB-BIO).

    Techniques: In Vivo, Expressing, Marker, Staining, Enzyme-linked Immunosorbent Assay, Injection, Flow Cytometry

    CCL24 knockout in colon epithelium reduces AOM/DSS-induced tumorigenesis and enhances CD8 + T cell function in mice. A, CCL24 fl/fl and Villin-Cre mice were allowed to mate to generate mice with colon epithelium-specific CCL24 conditional knockout (C24 cko ), followed by AOM/DSS challenge to induce colorectal tumorigenesis. B, Gross images of mouse colons. C, Tumor number and diameter in mouse colons. D-F, Populations of total CD8 + T cells (D), TNFA + (E), and GZMB + (F) CD8 + T cells in mouse tumor tissues. G, Anti-CD8 antibody treatment for CD8 + T cell depletion in AOM/DSS-challenged C24 cko mice after 8 weeks. H, Gross images of mouse colons. I, Tumor number and diameter in mouse colons. J, IHC detection of C-Cas-3 staining in tumor tissues. Each group includes 6-8 mice. Data are presented as bars and dots. p < 0.05 was considered statistically significant.

    Journal: International Journal of Biological Sciences

    Article Title: CCL24 recruits CCR3 + TAMs to promote immunosuppression via YAP1 activation and serves as a therapeutic target for Gracillin in colorectal cancer

    doi: 10.7150/ijbs.127341

    Figure Lengend Snippet: CCL24 knockout in colon epithelium reduces AOM/DSS-induced tumorigenesis and enhances CD8 + T cell function in mice. A, CCL24 fl/fl and Villin-Cre mice were allowed to mate to generate mice with colon epithelium-specific CCL24 conditional knockout (C24 cko ), followed by AOM/DSS challenge to induce colorectal tumorigenesis. B, Gross images of mouse colons. C, Tumor number and diameter in mouse colons. D-F, Populations of total CD8 + T cells (D), TNFA + (E), and GZMB + (F) CD8 + T cells in mouse tumor tissues. G, Anti-CD8 antibody treatment for CD8 + T cell depletion in AOM/DSS-challenged C24 cko mice after 8 weeks. H, Gross images of mouse colons. I, Tumor number and diameter in mouse colons. J, IHC detection of C-Cas-3 staining in tumor tissues. Each group includes 6-8 mice. Data are presented as bars and dots. p < 0.05 was considered statistically significant.

    Article Snippet: IHC was performed using anti-Cleaved-Caspase-3 (C-Cas-3) and anti-CCR3 antibodies (Cell Signaling Technology), with secondary antibodies visualized using a DAB detection system (ZSGB-BIO).

    Techniques: Knock-Out, Cell Function Assay, Staining

    Overexpression of Rhbdf2 exacerbated H/R-induced apoptosis and inflammatory response, whereas downregulation of Rhbdf2 significantly alleviates H/R-induced liver injury. ( A ) Analysis of Rhbdf2 protein and mRNA expression levels in Rhbdf2 overexpressing cell lines (OE) and vector control cell lines (VT) by Western blot and qRT-PCR analyses (n = 3 per group). ( B ) Western blot analysis of the protein expression levels and quantification of Bax, Bcl2, and C-caspase 3 in the OE group and the VT group before and after H/R (n = 3 per group). ( C ) Flow cytometry analysis of apoptosis rate and statistical analysis of cells in the OE and VT groups after H/R (n = 3 per group). ( D ) qRT-PCR analysis of mRNA levels of IL-6, IL-1β, and TNF-α in the OE and VT groups after H/R (n = 3 per group). ( E ) Western blot analysis and quantification of the expression levels of NF-κB signaling pathway-related proteins in cells from the OE and VT groups before and after H/R (n = 3 per group). ( F ) Western blot analysis and qRT-PCR analysis to determine the protein and mRNA expression levels of Rhbdf2 respectively in Rhbdf2 knockdown cells (SH1, 2, 3) and control cells (NC) (n = 3 per group). ( G ) Western blot analysis of the protein expression levels of Bax, Bcl2, and C-caspase3 in the cells of the SH1 and NC groups before and after H/R, and the results of statistical analysis (n = 3 per group). ( H ) Flow cytometry analysis of apoptosis rate of SH1 cells and NC cells before and after H/R, and statistical analysis (n = 3 per group). ( I ) qRT-PCR analysis of mRNA expression levels of inflammatory cytokines IL-6 , IL-1β, and TNF-α in SH1 and NC cells before and after H/R (n = 3 per group). ( J ) The expression levels and statistical analysis of NF-κB signaling pathway-related proteins in SH1 and NC cells before and after H/R (n = 3 per group). Using β-Actin as loading control; data are shown as the mean ± SD; ns indicates no statistical difference compared with control; ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001 indicate a statistical difference compared with control.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: Ubiquitination of Rhomboid 5 Homolog 2 by Constitutive Photomorphogenic 1 Alleviates Hepatic Ischemia-reperfusion Injury by Regulating the Transforming Growth Factor-β Activating Kinase 1-C-Jun N-terminal Kinase/p38 Signaling Pathway

    doi: 10.1016/j.jcmgh.2025.101695

    Figure Lengend Snippet: Overexpression of Rhbdf2 exacerbated H/R-induced apoptosis and inflammatory response, whereas downregulation of Rhbdf2 significantly alleviates H/R-induced liver injury. ( A ) Analysis of Rhbdf2 protein and mRNA expression levels in Rhbdf2 overexpressing cell lines (OE) and vector control cell lines (VT) by Western blot and qRT-PCR analyses (n = 3 per group). ( B ) Western blot analysis of the protein expression levels and quantification of Bax, Bcl2, and C-caspase 3 in the OE group and the VT group before and after H/R (n = 3 per group). ( C ) Flow cytometry analysis of apoptosis rate and statistical analysis of cells in the OE and VT groups after H/R (n = 3 per group). ( D ) qRT-PCR analysis of mRNA levels of IL-6, IL-1β, and TNF-α in the OE and VT groups after H/R (n = 3 per group). ( E ) Western blot analysis and quantification of the expression levels of NF-κB signaling pathway-related proteins in cells from the OE and VT groups before and after H/R (n = 3 per group). ( F ) Western blot analysis and qRT-PCR analysis to determine the protein and mRNA expression levels of Rhbdf2 respectively in Rhbdf2 knockdown cells (SH1, 2, 3) and control cells (NC) (n = 3 per group). ( G ) Western blot analysis of the protein expression levels of Bax, Bcl2, and C-caspase3 in the cells of the SH1 and NC groups before and after H/R, and the results of statistical analysis (n = 3 per group). ( H ) Flow cytometry analysis of apoptosis rate of SH1 cells and NC cells before and after H/R, and statistical analysis (n = 3 per group). ( I ) qRT-PCR analysis of mRNA expression levels of inflammatory cytokines IL-6 , IL-1β, and TNF-α in SH1 and NC cells before and after H/R (n = 3 per group). ( J ) The expression levels and statistical analysis of NF-κB signaling pathway-related proteins in SH1 and NC cells before and after H/R (n = 3 per group). Using β-Actin as loading control; data are shown as the mean ± SD; ns indicates no statistical difference compared with control; ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001 indicate a statistical difference compared with control.

    Article Snippet: C-caspase3 , CST , 9661T.

    Techniques: Over Expression, Expressing, Plasmid Preparation, Control, Western Blot, Quantitative RT-PCR, Flow Cytometry, Knockdown

    Overexpression of Rhbdf2 inhibits the protective effect of Cop1. ( A ) Plasmids carrying the indicated genes (VT, Cop1, Rhbdf2, Cop1+Rhbdf2) were transfected into AML12, and apoptotic rate of each group was determined by flow cytometry after H/R and statistical analysis (n = 3 per group). ( B ) Western blot analysis and statistical analysis of the expression levels of Bax, Bcl2, and C-caspase3 proteins in the indicated groups after H/R (n = 3 per group). ( C ) RT-PCR analysis of mRNA levels of IL-6, IL-1β , and TNF-α in the indicated groups after H/R (n = 3 per group). ( D ) Western blot analysis and quantitative analysis of the expression levels of NF-κB signaling pathway-associated proteins in each group after H/R (n = 3 per group). ( E ) Western blot analysis and quantification of the expression levels of TAK1, JNK, and p38 proteins and their phosphorylated proteins in each group after H/R (n = 3 per group). Using β-Actin as loading control; data are shown as the mean ± SD; ns indicates no statistical difference compared with control; ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001 indicate a statistical difference compared with control.

    Journal: Cellular and Molecular Gastroenterology and Hepatology

    Article Title: Ubiquitination of Rhomboid 5 Homolog 2 by Constitutive Photomorphogenic 1 Alleviates Hepatic Ischemia-reperfusion Injury by Regulating the Transforming Growth Factor-β Activating Kinase 1-C-Jun N-terminal Kinase/p38 Signaling Pathway

    doi: 10.1016/j.jcmgh.2025.101695

    Figure Lengend Snippet: Overexpression of Rhbdf2 inhibits the protective effect of Cop1. ( A ) Plasmids carrying the indicated genes (VT, Cop1, Rhbdf2, Cop1+Rhbdf2) were transfected into AML12, and apoptotic rate of each group was determined by flow cytometry after H/R and statistical analysis (n = 3 per group). ( B ) Western blot analysis and statistical analysis of the expression levels of Bax, Bcl2, and C-caspase3 proteins in the indicated groups after H/R (n = 3 per group). ( C ) RT-PCR analysis of mRNA levels of IL-6, IL-1β , and TNF-α in the indicated groups after H/R (n = 3 per group). ( D ) Western blot analysis and quantitative analysis of the expression levels of NF-κB signaling pathway-associated proteins in each group after H/R (n = 3 per group). ( E ) Western blot analysis and quantification of the expression levels of TAK1, JNK, and p38 proteins and their phosphorylated proteins in each group after H/R (n = 3 per group). Using β-Actin as loading control; data are shown as the mean ± SD; ns indicates no statistical difference compared with control; ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001 indicate a statistical difference compared with control.

    Article Snippet: C-caspase3 , CST , 9661T.

    Techniques: Over Expression, Transfection, Flow Cytometry, Western Blot, Expressing, Reverse Transcription Polymerase Chain Reaction, Control